null

Anti-Mouse CD40 In Vivo Antibody - Low Endotoxin

SKU:
IVMB0152
Product Type:
In Vivo Monoclonal Antibody
Clone:
FGK45
Protein:
CD40
Isotype:
Rat IgG2a
Reactivity:
Mouse
Synonyms:
Bp50
TNFRSF5
Research Area:
Immune Checkpoint & Cancer Biology
Endotoxin Level:
Low Endotoxin
Host Species:
Rat
Applications:
Act
FA
FC
€125 - €3,220
Frequently bought together:

Description

system_update_altTechnical Datasheet
Product Name:Anti-Mouse CD40 In Vivo Antibody - Low Endotoxin
Product Code:IVMB0152
Size:1mg, 5mg, 25mg, 50mg, 100mg
Clone:FGK45
Protein:CD40
Product Type:Monoclonal Antibody
Synonyms:Bp50, TNFRSF5
Isotype:Rat IgG2a
Reactivity:Mouse
Immunogen:Recombinant Mouse CD40 Fusion Protein
Applications:Act, FA, FC
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Purity:≥95% monomer by analytical SEC
>95% by SDS Page
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Act, FA, FC
Recommended Usage:FC
The suggested concentration for this FGK45 antibody for staining cells in flow cytometry is ≤ 1.0 µg per 106 in a volume of 100 µl. Titration of the reagent is recommended for optimal performance for each application.
Reactivity:Mouse
Host Species:Rat
Specificity:Clone FGK45 recognizes an epitope on mouse CD40.
Antigen Distribution:CD40 is widely expressed on antigen-presenting cells such as dendritic cells, B cells, macrophages, and monocytes, in addition to non-immune endothelial cells, basal epithelial cells, and a variety of tumors.
Immunogen:Recombinant Mouse CD40 Fusion Protein
Concentration:≥ 5.0 mg/ml
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Purity:≥95% monomer by analytical SEC
>95% by SDS Page
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

CD40 is a 48 kD type I transmembrane glycoprotein that is a member of the TNFR superfamily. CD40, in association with its ligand CD154 (CD40L) - a 39 kD protein, acts as a costimulatory molecule for the activation of B cells, dendritic cells, monocytes, and other antigen presenting cells. CD40 is involved in Ig isotype switching and dendritic cell maturation, as well as the activation, differentiation and proliferation of B cells. CD40 interacts with TNFR2 and is involved in the regulation of signal transduction. CD40 is a potential target for cancer immunotherapy. Blocking the interaction of CD40 with its ligand (CD154) is the sought-after therapeutic objective for preventing and/or improving both autoimmune diseases and transplant rejection. Studies have shown that monoclonal antibodies that block CD154 in human clinical trials resulted in unanticipated vascular complications. Hence, an interest in the therapeutic potential for antagonist mAbs specific for human CD40 is emerging. Antibodies of particular therapeutic interest are those that do not inhibit CD40 signaling via physical competition with CD154. Additionally, the interaction of CD40 and its ligand (CD154) is found to be essential for amyloid-beta-induced microglial activation, thus plays a significant part in Alzheimer disease pathogenesis.

Technical Datasheet:View
Protein:CD40
Ligand/Receptor:CD154
Research Area:Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Product Thumbnail
Rat IgG2a Isotype Control
Clone 1-1
Isotype Rat IgG2a
Endotoxin Level Low Endotoxin
Learn More

Meet the team!


Shane Costigan

Shane Costigan

Territory Manager & Team Lead

Abdul Khadim

Abdul Khadim

Sales Executive

Related Products